Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.75 |
| ▸ | NPC1 | O15118 | 6/20 | 0.75 |
| ▸ | RAB9A | P51151 | 6/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.75 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.75 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.58 |
| ▸ | HTR3B | O95264 | 2/20 | 0.58 |
| ▸ | HTR3A | P46098 | 2/20 | 0.58 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.58 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3283287 | 1.00 | MEN1 (0.75) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL10349716 | 0.93 | MEN1 (0.73) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL2291265 | 0.93 | MEN1 (0.73) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL12412502 | 0.87 | RAB9A (0.66) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL12412467 | 0.87 | NPC1 (0.66) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL14280920 | 0.87 | RAB9A (0.66) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL11891993 | 0.87 | RAB9A (0.66) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL29153271 | 0.87 | MEN1 (0.66) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL14408040 | 0.85 | MEN1 (0.59) | MEN1NPC1RAB9AKMT2AHSP90AA1 | |
| SCHEMBL12054241 | 0.85 | MEN1 (0.59) | MEN1NPC1RAB9AKMT2AHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9541795-B2 | Liquid crystal display device and method for manufacturing the same | SONY CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-9523889-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-12-20 | — | — | US | disclosed |
| US-9507210-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9470929-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9465244-B2 | Liquid crystal display | SONY CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9366910-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-9235084-B2 | Liquid crystal display device and manufacturing method thereof | SONY CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9146425-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20150146148-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
| US-20140111752-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2014-04-24 | — | — | US | disclosed |
| US-20140071390-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2014-03-13 | — | — | US | disclosed |
| US-20130155360-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20130010244-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION | 2013-01-10 | — | — | US | disclosed |
| US-20120218500-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-30 | — | — | US | disclosed |
| US-20120212691-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120212697-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120026440-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20110273652-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110157531-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | PYM1, PDCD2L, SDAD1 | MEN1 2607/4885NPC1 4025/4885RAB9A 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.